IP Library Patent Application 13740694
Patent Application
App. No. 13/740,694

Methods Of Gene Amplification And Expression

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/740,694
Abstract

Disclosed are methods relating to amplification and expression of a nucleic acid sequence encoding a polypeptide of interest in recombinant cells, and cell lines and polypeptides produced from such methods. The methods disclosed herein permit the amplification of cell lines that express a polypeptide of interest in a relatively short period of time through the use of a bioreactor.

Claims (19)

1 . A method for producing a recombinant cell line that expresses a polypeptide of interest, comprising (a) culturing a host cell in a bioreactor in media, wherein the host cell is transfected with (i) a nucleic acid sequence encoding a polypeptide of interest and (ii) a nucleic acid sequence encoding an amplifiable marker; and (b) adding an increasing amount of an amplification agent to the media to produce the recombinant cell line.

2 . The method of claim 1 wherein the nucleic acid sequence encoding a polypeptide of interest and the nucleic acid sequence encoding an amplifiable marker are contained on a single vector.

3 . The method of claim 1 wherein the amplifiable marker encodes a DHFR protein.

4 . The method of claim 1 wherein the host cells are mammalian cells.

5 . The method of claim 1 wherein the host cells are Cl-JO cells.

6 . The method of claim 1 wherein the polypeptide of interest is an antibody.

7 . The method of claim 1 wherein the bioreactor is a perfusion bioreactor.

8 . The method of claim 1 wherein the increasing amount of the amplification agent is added to the media when % cell viability is increasing or stable.

9 . A method for producing a polypeptide of interest, which comprises culturing host cells transfected with (i) a nucleic acid sequence encoding a polypeptide of interest and (ii) a nucleic acid sequence encoding an amplifiable marker in a bioreactor in media containing increasing amounts of an amplification agent, thereby expressing the polypeptide of interest.

10 . The method of claim 9 wherein the nucleic acid sequence encoding a polypeptide of interest and the nucleic acid sequence encoding an amplifiable marker are contained on a single vector.

11 . The method of claim 9 wherein the amplifiable marker encodes a DHFR protein.

12 . The method of claim 9 wherein the host cells are mammalian cells.

13 . The method of claim 9 wherein the host cells are CHO cells.

14 . The method of claim 9 wherein the polypeptide of interest is an antibody.

15 . The method of claim 9 wherein the bioreactor is a perfusion bioreactor.

16 . The method of claim 9 wherein the amplification agent is added in increasing amounts to the media when % cell viability is increasing or stable.

17 . The method of claim 9 , wherein the host cells are derived from the same single clone.

18 . The method of claim 9 , wherein the host cells are pooled multiple clones.

19 . The method of claim 9 , wherein the host cells are bulk transfectants.

Assignments (1)
MERGER Recorded Jun 13, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 030603/0924 →